HCA Healthcare Inc (NYSE:HCA)
$ 410.5 +17.26 (+4.39%) Market Cap: 91.07 Bil Enterprise Value: 143.30 Bil PE Ratio: 14.12 PB Ratio: 0 GF Score: 87/100

Q1 2025 HCA Healthcare Inc Earnings Call Transcript

Apr 25, 2025 / 02:00PM GMT
Release Date Price: $327.92 (-3.95%)

Key Points

Positve
  • HCA Healthcare Inc (HCA) reported a strong financial performance in Q1 2025, with diluted earnings per share increasing over 20% year-over-year to $6.45.
  • The company experienced broad-based volume growth, with inpatient admissions up 2.6%, equivalent admissions up 2.8%, and emergency room visits increasing by 4%.
  • Operating margins improved due to effective cost management, with adjusted EBITDA margins increasing by 110 basis points compared to the prior year.
  • HCA Healthcare Inc (HCA) expanded its network by increasing the number of facilities by 3.3% and inpatient bed capacity by 2%, indicating strategic growth.
  • The payer mix remained strong, with managed care equivalent admissions increasing by 5.4% and exchange admissions growing by 22.4% over the prior year.
Negative
  • Outpatient surgical volumes declined slightly, driven by lower acuity cases and reductions in Medicaid and self-pay volumes.
  • The company faces uncertainty regarding federal policy changes, which could impact operations, though specific effects are currently unclear.
  • Medicaid volumes began to flatten, with a same facility equivalent admission decline of 1.4% compared to the prior year.
  • There is ongoing concern about potential impacts from tariffs on supplies, with the situation described as fluid and uncertain.
  • Behavioral health volumes were down due to the repurposing of beds for medical-surgical use, impacting this segment's performance.
Operator

Welcome to HCA Healthcare's first-quarter 2025 earnings conference call. Today's call is being recorded.

At this time, for opening remarks and introductions, I would like to turn the call over to Vice President of Investor Relations, Mr. Frank Morgan. Please go ahead, sir.

Frank Morgan
HCA Healthcare Inc - Vice President of Investor Relations

Good morning, and welcome to everyone on today's call. With me this morning is our CEO, Sam Hazen; and CFO, Mike Marks. Sam and Mike will provide some prepared remarks, and then we'll take questions.

Before I turn the call over to Sam, let me remind everyone that should today's call contain any forward-looking statements, they are based on management's current expectations. Numerous risks and uncertainties and other factors may cause actual results to differ materially from those that might be expressed today. More information on forward-looking statements and these factors are listed in today's press release and in our various SEC filings.

On this morning's call, we may reference measures

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot